Hera Health Solutions

Hera Health Solutions is a pharmaceutical device company specializing in the research, development, and commercialization of long term treatments through proprietary biodegradable implants by using existing generic drugs in combination with already FDA-approved structural materials.

Our first product - Eucontra has a fully working prototype and is finalizing preclinical trials to prep for full FDA submission and approval.

Hera's first product, Eucontra aims to join and disrupt the worldwide contraceptive market valued at a $14B industry. Moreover, the long acting drug delivery market which can be utilized through our drug delivery platform is estimated to be valued at over $800B.

Offering quality and controlled medication over long periods of time is troublesome and requires invasive procedures. Current solutions on the market make it necessary for an expensive and complicated removal procedures. These procedures often leave behind heavy bruising, scarring, and even lost foreign objects in the body.

Proprietary biodegradable drug delivery implants created by using existing generic drugs in combination with already FDA approved structural materials will deliver trusted medication over extended periods of time.

Nexplanon
Copper Iud
Depo Provera

There are currently no products on the market that directly address the removal issuess of the contraceptive arm implant. The pricing of our product is competitive and offer a non invasive, effective, and discreet form.

Currently raising $1.25 MM Series Seed Round - Lead Investor Secured with leading Healthcare VC

Technology will be marketed and sold as pharmaceutical products that align with already existing reimbursement codes.

1. Non- GLP Preclinical Testing
2. PIND FDA Submission
3. WHO Pre Approval Submission
4. Prepare Clinical Study Preparation

Full Term sheet available on request

- FDA regulatory approval necessary for US sales & distribution
- World Health Organization pre-approval necessary for International sales & distribution

Zeroto510 - USA ranked accelerator
BioExel Program

1. Named Next Emerging Medical Device Innovation at International Competition
2. Startup of Year SXSW Winner
3. Get Started Startup Winner 2018
4. Get Started Medical Startup Winner 2018

Bioerodible Drug Delivery implants - patent pending - published patent - all rights assigned to Hera Health Solutions Inc.